National Institutes of Health

Pays up to $200,000 per prize (total $2.5M pool) to U.S. institutions with proven menopause-education curricula.

Awards a $3.1 million prize purse across four phases to help U.S. nonprofits and Tribes build the research capacity to lead maternal health research in maternity care deserts.

Awards up to $7,000,000 in cash prizes to teams building lab-based alternatives to animal testing.

Funds five university-based hubs that turn NIH-backed biomedical discoveries into products.

Pays up to $120,000 per Interim Milestone winner and up to $320,000 per Final Submission winner to US-based researchers, startups and institutions that build a working prototype technology able to target endogenous RNA in human disease.

Awards up to $13.1 million across three phases to US-based teams developing novel technologies that target RNA to treat human disease.

Paid up to $20,000 each to as many as 25 winners in Phase I of a three-phase NIH challenge for technologies that target RNA directly to treat human disease.

Funds two-site feasibility studies of meditation, yoga, acupuncture and similar interventions, before anyone attempts a full trial.

Offers NIEHS Worker Training support for HAZMAT and emergency response through practical e-learning tool development channels.

Funds U.S. undergraduate-focused colleges and universities running small-scale biomedical research through NIH's AREA (R15) grant.

Funds Research Facilities Construction Grant, NIH's C06 mechanism.

Funds Director’s Pioneer Award (NDPA), NIH's DP1 mechanism.

Invests innovative organizations in United States by guiding innovation from prototype work to stronger buyer demand.

Helps NIH IGNITE Program Innovation Grants to Nurture Initial Translational Efforts for Blueprint Neurotherapeutics Network.

Helps NHLBI Loan Repayment Programs for researchers committing to NHLBI-relevant research careers.

Funds Research Program Projects awards, NIH's P01 mechanism.

Funds Exploratory Grants, NIH's P20 mechanism.

Funds Center Core Grants, NIH's P30 mechanism.

Funds Animal (Mammalian and Nonmammalian) Model, and Animal and Biological Material Resource Grants, NIH's P40 mechanism.

Funds Biotechnology Resource Grants, NIH's P41 mechanism.

Funds Hazardous Substances Basic Research Grants Program (NIEHS), NIH's P42 mechanism.

Funds Specialized Center awards, NIH's P50 mechanism.

Funds Primate Research Center Grants, NIH's P51 mechanism.

Funds Collaborative International Research Project awards, NIH's PF5 mechanism.

Funds Research Transition Award, NIH's R00 mechanism.

Helps NIH Research Project Grant for established research programs for innovation and strategic advancement.

Administers innovative organizations in United States to build innovation work toward measurable commercialization outcomes.

Supports short United States investigator projects through NIH small research pathways for focused feasibility work and clear pilot results.

Funds Conference awards, NIH's R13 mechanism.

Funds schools NIH has not majorly funded before through small biomedical research grants.

Funds Research Excellence Award, NIH's R16 mechanism.

Funds Research Demonstration and Dissemination Projects awards, NIH's R18 mechanism.

Helps NIH Exploratory and Developmental Research Grant for novel ideas and preliminary studies.

Funds Resource-Related Research Projects awards, NIH's R24 mechanism.

Funds Exploratory/Developmental Grants Phase II awards, NIH's R33 mechanism.

Funds Planning Grant, NIH's R34 mechanism.

Funds Investigator-Focused Award, NIH's R35 mechanism.

Funds Research Specialist Award, NIH's R50 mechanism.

Funds Phase 1 Exploratory/Developmental Grant, NIH's R61 mechanism.

Funds High Impact Research and Research Infrastructure Programs, NIH's RC2 mechanism.

Funds non-profit and public health professional and graduate schools running small research projects through an NIH R15 grant.

Funds Research Project with Complex Structure awards, NIH's RM1 mechanism.

Funds Science-Driven Research Project awards, NIH's RP1 mechanism.

Funds Biomedical Research Support Shared Instrumentation Grants, NIH's S10 mechanism.

Funds Small Instrumentation Grants Program, NIH's S15 mechanism.

Funds non-dilutive support for United States small businesses in biomedical and behavioral health innovation.

Supports nonprofits and companies working with research institutions to turn scientific ideas into medical products.

Funds Research Project - Cooperative Agreements, NIH's U01 mechanism.

Funds Research Program - Cooperative Agreements, NIH's U19 mechanism.

Funds Resource-Related Research Projects - Cooperative Agreements, NIH's U24 mechanism.

Funds Planning Cooperative Agreement, NIH's U34 mechanism.

Funds Animal (Mammalian and Nonmammalian) Model, and Animal and Biological Materials Resource Cooperative Agreements, NIH's U42 mechanism.

Funds Specialized Center - Cooperative Agreements, NIH's U54 mechanism.

Funds High Impact Research and Research Infrastructure Cooperative Agreement Programs, NIH's UC2 mechanism.

Funds Clinical Research Cooperative Agreements - Single Project awards, NIH's UG1 mechanism.

Funds Phase 1 Exploratory/Developmental Cooperative Agreement, NIH's UG3 mechanism.

Funds National Network of Libraries of Medicine awards, NIH's UG4 mechanism.

Funds Exploratory/Developmental Cooperative Agreement Phase I awards, NIH's UH2 mechanism.

Funds Exploratory/Developmental Cooperative Agreement Phase II awards, NIH's UH3 mechanism.

Funds Research Project with Complex Structure Cooperative Agreement, NIH's UM1 mechanism.

Funds Resource Access Program, NIH's X01 mechanism.

Funds a statewide network of research-intensive and undergraduate institutions building biomedical research capacity in historically under-funded states.

Funds requests for biospecimen and data access from the ABCD, HBCD and PATH studies on adolescent brain development and tobacco use.

Funds a trial or study that integrates dental visits with medical screening and referral, run through a nationwide practice network.

Funds pharmacodynamic, pharmacokinetic and efficacy testing that shows a therapeutic agent has enough biological activity to justify further development.

Funds developing an assay and screening to identify a therapeutic agent, ahead of characterisation and efficacy testing on it.

Funds randomised controlled trials, up to seven years long, testing how nutritional interventions change chronic-disease risk factors across the life span.

Funds pilot and feasibility work that gets a substance use or HIV prevention project ready for a full research trial — not the trial itself.

Funds an early-career investigator's own research into the chronic conditions, coinfections and comorbidities that complicate long-term HIV.

Funds a small, short research project for a scholar who just finished NCATS's KL2 or K12 translational-science training.

Funds phased research that first maps the tissue mechanisms behind joint pain, then tests non-drug ways to treat it.

Funds exploratory brain and nervous system disorder research that pairs a US organisation with a partner in a low- or middle-income country.

Funds federally recognised Tribes and Tribal colleges to run their own health research, training and research infrastructure.

Funds a single ambitious research project that needs several investigators with different expertise working as one team, not separate grants.

Funds interdisciplinary research centers that speed up how mental-health treatments and services reach real-world practice, in youth and adults.

Funds a whole early-career research program at once, instead of one project, for investigators just starting out under NIGMS.

Funds a core center that pools already-funded substance-use, addiction and HIV investigators into one transformative research program.

Funds short, exploratory clinical trials — from first-in-human through Phase II — for arthritis, musculoskeletal and skin disease treatments.

Funds one Clinical and Translational Science Award Hub inside NIH's national network of academic medical centers.

Funds an existing translational science hub to build a specialised capability, platform or resource that unblocks a named roadblock. Forecast.

Funds the Trial Innovation Network, NIH's national effort to fix how multi-center clinical trials get designed and run.

Funds institutions already holding a Clinical and Translational Science Award to build shared approaches, technologies or models across the network. Forecast.

Funds mechanistic research into how non-addictive natural products actually relieve chronic pain, across the whole body.

Funds large pragmatic or implementation trials that test how well interventions work inside real health care settings.

Funds feasibility studies that are scientifically necessary to design the definitive clinical trial that follows them.

Funds research that builds on Native community strengths to prevent disease and get proven interventions adopted and sustained.

Funds a two-phase cooperative agreement to prepare for, then run, a clinical trial in arthritis, musculoskeletal or skin disease.

Funds digital health tools for underserved settings, built through two-way exchange between U.S. and low- or middle-income country researchers.

Funds a U.S. postdoctoral researcher or junior faculty member's salary and mentored research at a site in a low- or middle-income country.

Funds small-molecule drug candidates from a lab bench through Phase I testing, with NIH's own chemistry and toxicology experts on call.

Funds better drug dosing and safer medicines for pregnant women, lactating women, infants, children and adolescents.

Funds a grants office, research environment or pilot project upgrade at an HBCU, tribal college, or resource-limited institution invited to apply.

Funds research on how the cerebellum shapes cognition and mood in both healthy aging and Alzheimer's disease and related dementias.

Funds research into why smell declines with age or Alzheimer's disease, aimed at using it as a health indicator and finding new treatment targets.

Funds machine-learning and adaptive-design methods that build individual profiles, aimed at personalised prevention for cognitive and brain health.

Funds cross-ancestry, cross-species genomic studies of Alzheimer's disease and related dementias, aimed at therapeutic targets for precision medicine.

Funds a consortium of researchers, clinicians and EHR vendors building AI-enhanced platforms that scale proven primary-care interventions for older adults.

Funds the secure cloud platform that stores, harmonizes and shares Alzheimer's genetic and genomic data for the whole research community.

Funds a center of excellence built around one chosen theme in helping older adults stay independent.

Funds one clinical research network — a single $15 million award — running trials on new antibiotics, better use of old ones, and diagnostics.

Funds multidisciplinary centres solving the 3D structures of molecules behind HIV and other infectious diseases, aimed at structure-guided design.

Funds treatments and assessment devices ready before a civilian radiation or chemical mass-casualty emergency happens.

Funds lab models that stand in for animal testing in solid organ transplant research.

Funds the scientific leadership and research agenda for one center in NIH's HIV/AIDS Clinical Trials Network.

Funds the laboratory center that runs regulated testing for NIH's HIV/AIDS Clinical Trials Network.

Funds the statistics and data-management center that runs trial design, data quality and reporting for NIH's HIV network.

Funds the clinical trials units that enrol, treat and follow participants for NIH's HIV/AIDS trials network, open to non-US sites.

Funds one network running clinical trials and mechanism studies on training the immune system into tolerance for transplants and autoimmune disease.

Funds the shared data, safety-monitoring and statistics center behind NIAID's asthma, autoimmune and transplant clinical trial networks.

Funds a clinical trials network testing asthma prevention and treatment ideas in economically disadvantaged, high-burden urban children.

Funds multicenter clinical trials, with mechanism studies, testing ways to improve outcomes across heart, lung, kidney, liver and gut transplants.

Funds cooperative research centers on asthma, allergic and inflammatory airway disease, food and drug allergy, and atopic dermatitis.

Funds a multi-center group translating transplant tolerance regimens toward the clinic, so grafts survive without lifelong immune-suppressing drugs.

Funds translational centers building human microphysiologic systems — engineered tissue platforms — for infectious disease drug and biologic development.

Funds consortium research using multi-omics and AI on how infections cause chronic illness, and how chronic illness worsens infections.

Funds faster drug-susceptibility tests for tuberculosis and related mycobacterial infections that skip slow culture-based methods.

Funds basic and preclinical research toward more effective malaria vaccines, designed as a model for other mosquito-borne diseases too.

Funds mapping how joint tissue is wired by pain-sensing nerves, expanding a running NIH consortium.

Funds a single award to build the coordination network, standards and shared framework for consciousness research across fourteen NIH institutes.

Funds work on changing how health systems deliver care to people who have both chronic pain and opioid use disorder at once. Forecast.

Funds a multi-lab effort to catalogue which brain-cell populations addiction and drug exposure recruit or change.

Funds sensors and models that track complex behaviour and neural activity together, in real time, across species.

Funds developing and validating gene-editing tools in animal and other model systems used to study the human brain.

Funds single-cell research into how opioid use and HIV interact in brain tissue, building on the SCORCH consortium's first phase.

Funds a laboratory that procures and distributes human ear tissue to researchers studying hearing and balance disorders.

Funds the single hub that coordinates communication across labs in NIDCD's national ear-tissue research network.

Funds research improving how late talking children get screened, diagnosed and referred to care in their first three years.

Funds genomic research centres hunting the genetic and biological roots of inflammatory bowel disease.

Funds one of up to six clinical research centers studying disorders where the gut and nervous system miscommunicate, from gastroparesis to related conditions.

Funds the single data coordinating center for NIDDK's inflammatory bowel disease genetics consortium, managing biospecimens and data from its research centers.

Funds centres that provide specialised research services to investigators at other institutions, in NIDDK's obesity and diabetes mission areas.

Funds one center coordinating training, best practice and shared data infrastructure across every extreme-weather health hub in the same initiative.

Funds a multi-site Autism Centers of Excellence network as one R01 award with sub-awards to every collaborating site.

Funds a multi-site Autism Centers of Excellence programme as a P50 center grant, alongside a companion R01 version of the same initiative.

Funds mapping how nutrients, drugs and chemicals cross the placenta, gut, mammary gland and blood-brain barrier in pregnancy and infancy.

Funds specialised centers running basic, translational and clinical muscular dystrophy research together, with patients built into the design.

Funds research on whether HIV immunotherapies reach and calm the brain's viral reservoir without causing neurological harm.

Funds the coordinating hub that keeps brain cell atlas data usable, reproducible and shared across the whole BRAIN Initiative network.

Funds building a web-accessible archive that stores, curates and shares data from BRAIN Initiative research, with tools to use it.

Funds building new tools to record, image or control brain cells and circuits, from first sketches to lab-ready instruments.

Funds a network generating genetic, cellular and molecular data from human pain tissue, as part of NIH's HEAL pain initiative.

Funds research on how toxins, sleep, stress and other everyday exposures mechanistically shape Alzheimer's-related dementia.

Funds a multi-institution consortium investigating the mechanisms behind neurodegeneration in Alzheimer's-related dementias.

Funds phased research proving a newly identified Alzheimer's-related dementia target truly causes the disease process it's linked to.

Funds the operations hub and the data hub that keep NIH's emergency-care clinical trials network running.

Funds the clinical sites that enroll patients into NIH's emergency-care trials network for neurological and cardiovascular emergencies.

Funds multidisciplinary centers researching tobacco addiction, marketing, and harm, to give FDA the science behind its regulations.

Funds centers that take working RNA-analysis technology and push it further, not invent something new from scratch.

Funds early, high-risk RNA technology not yet proven at scale, developed through two milestone-gated phases.

Funds RNA reference standards so labs can compare results and trust their instruments across the RNomics program.

Funds projects that connect Common Fund datasets to other NIH data ecosystems, so they're easier to find and reuse.

Funds a network of centers that builds the methods to judge whether biomedical AI can actually be trusted.